http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-344532-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b04f5b6a02051c94d6eaf190b751ed2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-00
filingDate 1929-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1931-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-344532-A
titleOfInvention Manufacture of organic arsenic and antimony compounds
abstract Organo arsenic and antimony compounds are prepared by exchanging in known manner the hydroxyl group for X in compounds of the formula Y.Ar.NH.CO.(CH2)n.X, in which Y represents a residue containing arsenic or antimony in a tri- or penta-valent form, X signifies an amino group or a halogen atom, Ar stands for a substituted or unsubstituted aryl residue (but when X is halogen, Ar must not contain a hydroxyl group in orthoposition to the halogen-acylamino group), and n is an integer. According to the examples, (1) arsanilic acid is treated with chloracetyl chloride and then with caustic soda to give p-glycollylaminophenylarsinic acid; the same product is obtained by treating the chloracetylarsanilic acid with ammonia and decomposing the resulting glycylarsanilic acid with sodium nitrite in the presence of hydrochloric acid; (2) p-glycollylaminophenylarsenoxide is formed when p-aminophenylarsenoxide is acylated with chloracetyl chloride and the product heated with caustic soda; (3) 3-methyl-4-aminophenylarsinic acid is treated first with chloracetyl chloride and then with ammonia, and the 3-methyl-4-glycylaminophenylarsinic acid is then decomposed with nitrous acid to give 3-methyl-4-glycollylaminophenylarsinic acid; (4) p-glycollylaminophenylstibinic acid is produced when the product of interaction of p-aminophenylstibinic acid and chloracetyl chloride is boiled with caustic soda solution; (5) 2-methyl-4-aminophenylarsinic acid is treated with chloracetyl chloride or a -bromopropionyl bromide and the resulting compound decomposed with caustic soda; the product comprises 2-methyl-4-glycollylaminophenylarsinic acid and 2-methyl-4-lactylaminophenylarsinic acid respectively. The Specification as open to inspection under Sect. 91 (3) (a) also states that X may represent an acid residue, and contains Examples according to which 2-hydroxy-4-aminophenylarsinic acid, 4-methoxy-3-aminophenylarsinic acid and 2:5-dimethyl-4-aminophenylarsinic acid are treated with chloracetyl chloride and the products heated with caustic soda solution to give the corresponding glycollylamino compounds. This subject-matter does not appear in the Specification as accepted.
priorityDate 1929-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154237168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432242517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71432026
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486425
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429281743
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432255377
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23668193
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154119267
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586572
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426087511
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429281744
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428411213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431986007
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5464511
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154244363
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450649535
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432208547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153802351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414875322
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID153802352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154217772
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14290
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5354495
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549163

Total number of triples: 45.